Price $0.73 |
Market Cap
46.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.35
|
P/S
2.0
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-18.4K
|
FCF
-0.2
|
|
Op. Margin
-184.70%
|
Net Margin
-188.30%
|
ROE
-115.90%
|
ROI
-76.90%
|
|
ROA
-78.50%
|
EPS Growth
33.30%
|
Current Ratio
1.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| American Bio Medica Corporatio (ABMC) | $0.22 | - | - | 4.7M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.68 | - | - | 19.8M | Strong Buy |
| IntriCon Corporation (IIN) | $18.10 | - | - | 162.6M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $11.96 | - | - | 10.6B | Strong Buy |
| IRIDEX Corporation (IRIX) | $5.75 | - | - | 39.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
